TNP1 and neoplasm: Importantly, benefitting from the full OFF function of the nanophotosensitizer in the bloodstream prior to entering tumor cells, the intravenous treatment using TNP1/ZnPc did not cause noticeable skin phototoxicity or any other adverse side effects, even when exposed to simulated sunlight irradiation.